Reporting

1.1

Unless otherwise stated, this Part applies to:

1. (1) a UK Solvency II firm; and
2. (2) in accordance with General Application 3, the Society.
3. (3) in accordance with General Application 3, managing agents, for the purposes of 7.

1.2

In this part, the following definitions shall apply:

assessable mutual

means a mutual whose articles of association, rules or bye-laws provide for the calling of additional contributions from members.

Lloyd’s templates

means the:

1. (1) annual solvency return;
2. (2) quarterly solvency return;
3. (3) annual asset data; and
4. (4) quarterly asset data

reporting templates that the Society has made available to managing agents to enable the Society to collect information from syndicates in order to complete the Society’s reporting under this Part.

material pooling agreement

means an arrangement in which:

1. (1) insurance or reinsurance undertakings only are members;
2. (2) the members have assumed joint liability between themselves for a portfolio of insurance or reinsurance obligations in defined proportions (which are adjustable should one of the members default to ensure that any claim is fully met);
3. (3) the members have the capacity to accept pooled insurance risks with a gross exposure to any one loss exceeding USD 1 Billion.

mixed commercial package

means contracts of insurance (other than treaty reinsurance contracts) against more than one of:

1. (1) loss or damage to property;
2. (2) risks to the person insured incurring liabilities to third parties;
3. (3) risks of loss to the persons insured arising from the failure of debtors of theirs to pay their debts when due;
4. (4) risks of loss to the persons insured attributable to interruptions of business carried on by them;
5. (5) risks of loss to the persons insured attributable to their incurring unforeseen expenses; or
6. (6) any other risk of loss to a commercial operation;

where the risks and losses covered in the contract are rated on a single package basis and no separately identifiable premium is charged or recorded for internal management purposes for any one group of risks or losses specified in the contract.

professional indemnity

means contracts of insurance (other than treaty reinsurance contracts), including directors’ and officers’ liability and error and omissions liability, against the risks of the persons insured incurring liabilities to third parties arising from wrongful acts (such as breach of duty, breach of trust, negligence, error or omissions) by professionals, named individuals or businesses occurring in the course of the insured’s professional activities.

public and products liability

means contracts of insurance (other than treaty reinsurance contracts) against the risks of persons insured incurring liabilities to third parties for damage to property, injury, illness or death, arising in the course of the insured’s business.

2.1

A firm must submit to the PRA information which is necessary for the purposes of the PRA’s supervision of the firm.

[Note: Art. 35(1) of the Solvency II Directive]

2.2

The information referred to in 2.1 must:

1. (1) be submitted in the applicable format or template (if any) provided in the Solvency II Regulations or in the form of any national specific template where applicable; and
2. (2) include at least the information necessary to enable the PRA to assess the matters set out below when performing the supervisory review process:
1. (a) the firm’s system of governance;
2. (b) the business pursued by the firm;
3. (c) the valuation principles applied by the firm for solvency purposes;
4. (d) the risks faced by the firm;
5. (e) the risk management systems of the firm; and
6. (f) the capital structure, capital needs and capital management of the firm, and
3. (3) enable the PRA to make any appropriate decisions resulting from the exercise of their supervisory rights and duties.

[Note: Art. 35(1) of the Solvency II Directive]

2.3

The information referred to in 2.1 and 2.2 must comprise the following:

1. (1) qualitative or quantitative elements, or any appropriate combination thereof;
2. (2) historic, current or prospective elements, or any appropriate combination thereof; and
3. (3) data from internal or external sources, or any appropriate combination thereof.

[Note: Art. 35(3) of the Solvency II Directive]

2.4

The information which a firm submits to the PRA in accordance with 2.1 and 2.2 must comply with the following principles:

1. (1) it must reflect the nature, scale and complexity of the business of the firm, and in particular the risks inherent in that business;
2. (2) it must be accessible, complete in all material respects, comparable and consistent over time; and
3. (3) it must be relevant, reliable and comprehensive.

[Note: Art. 35(4) of the Solvency II Directive]

2.5

A firm must have in place appropriate systems and structures to fulfil the requirements set out in 2.1 to 2.4, as well as a written policy approved by its governing body ensuring the ongoing appropriateness of the information submitted by the firm to the PRA.

[Note: Art. 35(5) of the Solvency II Directive]

2.6

Subject to 2.7, a firm falling within categories (1) to (7) must submit to the PRA the corresponding national specific templates on an annual basis:

1. (1) [Deleted]
2. (1A) All firms must submit template NS.00: Basic Information;
3. (2) A firm which manages a material pooling agreement must submit template NS.03: Material Pooling Arrangements;
4. (3) An assessable mutual which:
1. (a) has called for an additional contribution after 1 January 2006; or
2. (b) has received approval for ancillary own funds as contemplated in Own Funds 2.3(4)
5. must submit template NS.04: Assessable Mutuals;
6. (4) A firm writing suretyship business the effect of which is to improve the credit rating of the underlying security must submit template NS.08: Business Model Analysis – Financial Guarantee Insurers;
7. (5) A long-term insurer must submit:
1. (a) NS.01: With-Profits Value of Bonus if net best estimate liabilities for with-profits insurance business are more than £500m and the firm is a single with-profits fund;
2. (b) NSR.01: With-Profits Value of Bonus for each ring-fenced fund which is also a with-profits fund and for the remaining part where this is a with-profits fund if net best estimate liabilities for with-profits insurance business are more than £500m for the firm as a whole;
3. (c) NS.02: With-Profits Assets and Liabilities if net best estimate liabilities for with-profits insurance business are more than £500m and the firm is a single with-profits fund;
4. (d) NSR.02: With-Profits Assets and Liabilities for each ring-fenced fund which is also a with-profits fund and for the remaining part where this is a with-profits fund if net best estimate liabilities for with-profits insurance business are more than £500m for the firm as a whole;
5. (e) NS.05: Revenue Account - Life;
6. (f) NSR.05 Revenue Account – Life for the remaining part and each ring-fenced fund which is also a with-profits fund if the firm has one or more ring-fenced funds which is also a with-profits fund;
7. (g) NS.06: Business Model Analysis – Life if gross technical provisions for life business (including health similar to long-term business) are more than £500m; and
8. (h) NS.09: Best Estimate Assumptions for Life Insurance Risks;
8. (6) A general insurer must submit template NS.07: Business Model Analysis - Non-life;
9. (7) A general insurer carrying on insurance business and proportional and non-proportional reinsurance obligations relating to:
1. (a) railway rolling stock;
2. (b) aircraft;
3. (c) ships;
4. (d) goods in transit;
5. (e) motor vehicle liability;
6. (f) aircraft liability;
7. (g) liability of ships; or
8. (h) general liability
10. must submit template NS.10: Projection of Future Cash Flows (Best Estimate - Non Life: Liability Claim Types);
11. (8) A general insurer carrying on insurance business relating to:
1. (a) employers’ liability (including as part of a mixed commercial package);
2. (b) public and products liability (including as part of a mixed commercial package; or
3. (c) professional indemnity

must submit template NS.11: Non-Life Insurance Claims Information (General Liability Sub-classes).

2.7

A firm falling within 2.6(2), 2.6(3)(a) or 2.6(6) that does not have a Part 4A permission to effect contracts of insurance is not subject to the obligation to complete the corresponding national specific template.

2.8

The Society must submit to the PRA the following national specific templates:

1. (1) template NS.12: The Society of Lloyd’s Solvency Capital Requirement on an annual basis; and
2. (2) template NS.13: The Society of Lloyd’s Minimum Capital Requirement on a quarterly basis.

2.9

For the purposes of 2.6 and 2.8, all amounts shown in units must be reported in UK sterling unless the national specific template expressly states otherwise.

2.10

A firm shall submit the annual national specific templates referred to in 2.6 and 2.8(1), after the end of the transitional period set out in Transitional Measures 3.1, no later than 14 weeks after the firm’s financial year end.

2.11

The Society shall submit the quarterly national specific templates referred to in 2.8(2) after the end of the transitional period set out in Transitional Measures 3.3, no later than 5 weeks after any quarter ending.

2.12

If the due date for the national specific template falls on a day which is not a business day, the documents must be submitted no later than the next business day after the due date.

2.13

1. (1) A firm, other than a friendly society, shall submit to the PRA, the national specific templates referred to in 2.6 and 2.8 in electronic format.
2. (2) A friendly society shall submit to the PRA the national specific templates referred to in 2.6 and 2.8 in electronic format or by post or by hand to the Regulatory Data Group, Statistics and Regulatory Data Division (HO5 B-D), Bank of England, Threadneedle Street, London EC2R 8AH; or via fax to the Regulatory Data Group of the Bank of England on 020 7601 3334.

2.14

Where a firm notifies the PRA that any of its submissions of national specific template submissions under 2.6 or 2.8 is incorrect, or where the PRA notifies a firm that any part of the national specific template appears to it to be inaccurate or incomplete, the firm must promptly make any appropriate corrections or adjustments and if necessary re-submit the national specific template (or relevant part of it).

3.1

A firm must disclose publicly, on an annual basis, a SFCR.

[Note: Art. 51(1) of the Solvency II Directive]

3.2

The information which a firm discloses in its SFCR must include the information required in 2.3 and must comply with the principles in 2.4.

[Note: Art. 51(1) of the Solvency II Directive and the Solvency II Regulations]

3.3

A firm’s SFCR must contain the following information, either in full or by way of reference to equivalent information, both in nature and scope, disclosed publicly under other legal or regulatory requirements:

1. (1) a description of the business and performance of the firm;
2. (2) a description of the system of governance of the firm and an assessment of its adequacy for the risk profile of the firm;
3. (3) a description of the risk exposure, risk concentration, risk mitigation and risk sensitivity separately for each category of risk of the firm;
4. (4) a description, separately for assets, technical provisions and other liabilities, of the bases and methods used for their valuation, together with an explanation of any major differences in the bases and methods used for the valuation of those assets, technical provisions and other liabilities in financial statements of the firm; and
5. (5) a description of the capital management of the firm, including at least the following:
1. (a) the structure, amount and quality of own funds of the firm, together with the information specified in 3.5;
2. (b) the amount of the MCR and SCR of the firm, together with the information specified in 3.6;
3. (c) information showing and explaining the main differences between the underlying assumptions of the standard formula and the underlying assumptions of any internal model for which the firm has received internal model approval; and
4. (d) the amount of any non-compliance with the MCR or any significant non-compliance with the SCR during the reporting period, even if subsequently resolved, with an explanation of the origin of that non-compliance and its consequences, as well as any remedial measures taken in respect of that non-compliance.

[Note: Art. 51(1)(a)–(e) of the Solvency II Directive]

3.4

For the purposes of 3.3(4), where a firm applies:

1. (1) a matching adjustment in accordance with Technical Provisions 6, the firm must include in the description:
1. (a) a description of the matching adjustment and of the portfolio of obligations and assigned assets to which the matching adjustment is applied; and
2. (b) a quantification of the impact of a change to zero of the matching adjustment on the firm’s financial position;
2. (2) a volatility adjustment in accordance with Technical Provisions 8, the firm must include in the description:
1. (a) a statement on whether the volatility adjustment referred to in Technical Provisions 8 is used by the firm;
2. (b) quantification of the impact of a change to zero of the volatility adjustment on the firm’s financial position.

[Note: Art. 51(1a) of the Solvency II Directive and the Solvency II Regulations]

3.5

The disclosure required by 3.3(5)(a) must include the following:

1. (1) an analysis of any significant change in the structure, amount and quality of own funds of the firm as compared to the previous reporting period of the firm;
2. (2) an explanation of any major differences in relation to the value of elements of own funds items in the financial statements of the firm; and
3. (3) a brief description of the capital transferability of the own funds of the firm.

[Note: Art. 51(2) of the Solvency II Directive]

3.6

The changes to this rule are effective from 23:00 on 31/12/2020.

The disclosure required by 3.3(5)(b) must include the following:

1. (1) the amount of the SCR calculated by the firm using the standard formula or, where the firm has received internal model approval, the amount of the SCR calculated using its internal model and, where applicable in the case of a partial internal model, the standard formula;
2. (2) the amount of any capital add-on imposed upon the firm by the PRA together with concise information on the justification given by the PRA for its imposition; and
3. (3) the impact of any undertaking specific parameters the firm is required to use in calculating the standard formula by the PRA together with concise information on the justification given by the PRA for requiring the use of those undertaking specific parameters.

[Note: Art. 51(2) of the Solvency II Directive]

3.7

The disclosure of the SCR required by 3.3(5)(b) must be accompanied, where applicable, with a statement indicating that the final amount of the SCR is subject to supervisory assessment.

[Note: Art. 51(2) of the Solvency II Directive]

3.8

Where a firm, in its SFCR, makes use of, or refers to, public disclosures made by the firm under other legal or regulatory requirements, those disclosures must be equivalent to the information required to be disclosed under 3.3 to 3.7, in both their nature and scope.

[Note: Art. 53(3) of the Solvency II Directive]

4.1

Where a firm is granted a waiver by the PRA permitting the firm not to disclose information otherwise required to be disclosed pursuant to 3.3(1) to (4) and 3.4 in its SFCR, the firm must make a statement to this effect in its SFCR and state whether the non-disclosure is permitted because:

1. (1) the disclosure of that information would enable competitors of the firm to gain a significant, undue advantage; or
2. (2) the firm has obligations to policyholders or other counterparty relationships which bind the firm to secrecy or confidentiality.

[Note: Art. 53(1) and Art. 53(2) of the Solvency II Directive]

5.1

In the event of any major development affecting significantly the relevance of the information disclosed in accordance with:

1. (1) 3.3 to 3.8; or
2. (2) 4.1;

a firm must disclose publicly appropriate information on the nature and effects of that major development.

[Note: Art. 54(1) of the Solvency II Directive]

5.2

Without limiting the general application of 5.1, for the purposes of that rule the following will be regarded as a major development:

1. (1) non-compliance with the MCR by the firm and either the PRA considers that the firm will not be able to submit, or the PRA does not receive within one month of the date of observation by the firm of non-compliance with the MCR, a finance scheme in accordance with Undertakings in Difficulty 4.1; and
2. (2) significant non-compliance with the SCR by the firm and the PRA does not receive, within two months from the date when non-compliance with the SCR was first observed by the firm, a recovery plan as required by Undertakings in Difficulty 3.1(2).

[Note: Art. 54(1) of the Solvency II Directive]

5.3

Where the circumstances described in 5.2(1) or 5.2(2) arise, the firm must immediately publicly disclose the amount of non-compliance with the MCR or SCR as the case may be, together with an explanation of the origin and consequences of that non-compliance, and a description of any remedial measures taken.

[Note: Art. 54(1) of the Solvency II Directive]

5.4

Where compliance with the MCR has not been restored by a firm within three months after the first observation of non-compliance by the firm, then the firm must publicly disclose at the end of that three-month period the non-compliance with the MCR, together with an explanation of the origin and consequences of that non-compliance, a description of any remedial measures taken and of any further remedial measures planned.

[Note: Art. 54(1) of the Solvency II Directive]

5.5

Where compliance with the SCR has not been restored by a firm within six months after the first observation of non-compliance by the firm, then the firm must publicly disclose at the end of that six-month period the non-compliance with the SCR, together with an explanation of the origin and consequences of that non-compliance, a description of any remedial measures taken and of any further remedial measures planned.

[Note: Art. 54(1) of the Solvency II Directive]

6.1

A firm must have in place:

1. (1) appropriate systems and structures to fulfil the requirements of 3 to 5; and
2. (2) a written policy ensuring the ongoing appropriateness of any information disclosed:
1. (a) in accordance with the requirements referred to in (1); and
2. (b) on a voluntary basis as further information or explanation related to the SFCR which is not already required to be disclosed.

[Note: Art. 55(1) of the Solvency II Directive]

6.2

A firm must ensure that its SFCR is:

1. (1) subject to approval by its governing body; and
2. (2) not publicly disclosed until the approval referred to in (1) is received.

[Note: Art. 55(2) of the Solvency II Directive]

7.1

A managing agent must, as promptly as possible, submit any information to the Society that is necessary for the Society to comply with its obligations in this Part or under the Solvency II Regulations.

7.2

The information in 7.1 must be submitted in the form that the Society requires.

7.3

The Society must provide to the PRA in electronic format the Lloyd’s templates it receives from each managing agent on behalf of each respective syndicate that the managing agent manages at the same time it submits its national specific templates required by 2.8.

8.0

NS.00 can be found here.

8.1

NS.01 can be found here.

8.2

NS.02 can be found here.

8.3

NS.03 can be found here.

8.4

NS.04 can be found here.

8.5

NS.05 can be found here.

8.6

NS.06 can be found here.

8.7

NS.07 can be found here.

8.8

NS.08 can be found here.

8.9

NS.09 can be found here.

8.10

NS.10 can be found here.

8.11

NS.11 can be found here.

8.12

NS.12 can be found here.

8.13

NS.13 can be found here.